Skip to content

Comparison Effectiveness of Rectal Misoprostol & Intravenous Tranexamic Acid Reducing Hemorrhage in Myomectomy

The Comparison of the Effectiveness of Rectal Misoprostol and Intravenous Tranexamic Acid in Reducing Intraoperative Bleeding in Patients Undergoing Myomectomy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06114758
Enrollment
75
Registered
2023-11-02
Start date
2023-09-01
Completion date
2024-11-01
Last updated
2023-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of Drug, Hemorrhage, Surgical, Myoma;Uterus, Postoperative Complications, Postoperative Hemorrhage

Keywords

myoma uteri, fibroids, hemmorhage, prostoglandinf2α, tranexamic acid

Brief summary

Fibroids are the most commonly encountered tumors in the female reproductive system. In patients, fibroids most often lead to abnormal uterine bleeding and the resulting anemia. In some cases, they can cause infertility or habitual abortions. Another complaint caused by fibroids is pain due to pressure and effects on adjacent organs. Very large fibroids can lead to abdominal swelling. Therefore, if a patient becomes symptomatic due to fibroids, myomectomy or, if necessary, hysterectomy is required. Because fibroids have a significant blood supply, there is a high risk of intraoperative bleeding and related complications. Additionally, the most common complication in these patients after the operation is bleeding. In many of these patients, intraoperative or postoperative blood transfusions are performed. If bleeding cannot be intervened early in these patients, hemodynamic instability, shock, coagulopathy, and, in the final stage, death can occur due to hemorrhage. Therefore, both intraoperative and postoperative bleeding control is of vital importance in patients undergoing myomectomy.

Detailed description

In this study, data of patients admitted with a diagnosis of uterine fibroids to the Department of Obstetrics and Gynecology, Women's Health and Obstetrics (EŞH) between September 1, 2022, and Sempember 1, 2024, who underwent myomectomy (either laparotomic or laparoscopic), will be collected. The parameters to be examined in the research are as follows: 1. Patients' postoperative 1st, 2nd, and 6th-hour vital signs (pulse rate, systolic and diastolic blood pressure, temperature, oxygen saturation). 2. Shock indices. 3. Hemogram and hematocrit values at 6-24 hours postoperatively. 4. Duration of the surgery. 5. Adverse effects experienced by the patients. 6. Additional treatments administered. 7. Whether blood transfusion was performed or not. In this study, the G-power analysis program was used to determine the minimum sample size, taking into account a 10% margin of error. According to the analysis results, the minimum number of patients to be included in the study for a total of 75 patients across 3 groups was determined. Statistical analysis of the data obtained in the study will be conducted using the SPSS Statistics 22 software package. A 95% confidence interval will be calculated for each variable, and results will be considered statistically significant for p \< 0.05.

Interventions

DRUGCytotec 200Mcg Tablet

the admistiration of 400 Mcg rectal cytotec while starting the surgery, just before the patient is covered

DRUGTransamine

1 gram intravenous slow infusion intraoperatively as we start the laparatomy

Sponsors

Ankara Etlik City Hospital
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Patients over 18 years of age * Laparotomic myomectomy surgeries * Laparoscopic myomectomy surgeries

Exclusion criteria

* Identifying missing or suspicious data related to the patient * Administering both intraoperative and postoperative medications to the patient

Design outcomes

Primary

MeasureTime frameDescription
Comparison of patients' preoperative and postoperative hemogram levels24 hoursThe basal hemogram levels ( gr/dL) of the patients will be compared with the hemogram levels at 6 and 24 hours.
Comparison of patients' preoperative and postoperative hematocrit levels24 hoursThe basal hematocrit levels (%) of the patients will be compared with the hematocrit levels at 6 and 24 hours.
Comparison of patients' postoperative shock indices6 hourpostoperative 1st, 2nd, and 6th-hour shock indices (heart rate (beats in minute) / systolic blood pressure(mmHg) ) will be compared

Secondary

MeasureTime frameDescription
Comparison of the patients' postoperative heart rate6 hourPatients postoperative 1st, 2nd, and 6th-hour heart rate (beats in minute) will be compared
Comparison of the patients' postoperative systolic and diastolic blood pressure6 hourPatients postoperative 1st, 2nd, and 6th-hour systolic and diastolic blood pressure (mmHg) will be compared

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026